Table 3 Lifetime costs and life expectancy results for base case and sensitivity analyses
Scenario | Strategy | Lifetime costs | Life expectancy (years from screening) | |
|---|---|---|---|---|
Societal perspective | Clinic perspective | |||
Base case | Preventative cryotherapy | $99 | $19 | 17.3 |
VIA | $196 | $94 | 17.1 | |
PAP | $219 | $124 | 17.1 | |
HPV | $223 | $113 | 17.1 | |
VIAÂ +Â HPV | $258 | $150 | 17.0 | |
HPVÂ +Â PAP | $261 | $155 | 17.0 | |
VIAÂ +Â PAP | $263 | $158 | 17.0 | |
Sensitivity analyses | ||||
 Low CD4 (CD4 ≤ 200 cells/mL) | Preventative cryotherapy | $122 | $22 | 15.3 |
VIA | $208 | $87 | 15.2 | |
HPV | $262 | $125 | 15.2 | |
PAP | $281 | $152 | 15.1 | |
VIAÂ +Â HPV | $339 | $194 | 15.0 | |
HPVÂ +Â PAP | $342 | $199 | 15.0 | |
VIAÂ +Â PAP | $348 | $205 | 15.0 | |
 High CD4 (CD4 > 500 cells/mL) | Preventative cryotherapy | $49 | $13 | 20.0 |
VIA | $99 | $51 | 19.9 | |
HPV | $102 | $56 | 19.9 | |
VIAÂ +Â HPV | $105 | $69 | 19.9 | |
PAP | $115 | $71 | 19.9 | |
HPVÂ +Â PAP | $119 | $80 | 19.9 | |
VIAÂ +Â PAP | $105 | $72 | 19.8 | |